RDTCF (Rapid Dose Therapeutics) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Aug. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Rapid Dose Therapeutics's net issuance of preferred for the three months ended in Aug. 2024 was $0.00 Mil. The number is 0, which means that Rapid Dose Therapeutics has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Rapid Dose Therapeutics's net issuance of preferred for the trailing twelve months (TTM) ended in Aug. 2024 was $0.00 Mil.

Rapid Dose Therapeutics Net Issuance of Preferred Stock Historical Data

The historical data trend for Rapid Dose Therapeutics's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Net Issuance of Preferred Stock Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Rapid Dose Therapeutics Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Rapid Dose Therapeutics Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Rapid Dose Therapeutics Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

DOSE:Canada

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.